Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 — Metairie, Louisiana

Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 is a clinical research site located in Metairie, Louisiana, United States 70006.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Metairie

Browse all research sites in Louisiana · View every site in Metairie

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2?

Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 conducted?

Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 has 1 clinical trials on record. Their work covers Breast Cancer.

Is Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 accredited by Crixeo Clinical Trials?

Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Crescent City Research Consortium, LLC Dept of Hem&Onc Specialist - 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.